IBB Company Profile and Key Details

Short-term trend indicators are bearishly aligned (SMA20 0.08%, SMA50 0.79%, SMA200 16.12%). The stock’s 14-day RSI is 50.72 (neutral), while the ATR of 3.3 points to moderate volatility. The stock remains sitting in the mid-range of its 52-week band, trading -3.21% below its high and over 61.85% above its low. Average 10-day trading volume of 1.57 million shares is in line with the 3-month average of 1.59 million, indicating normal recent market interest.

iShares Biotechnology ETF last paid a dividend of 0.41 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.00.

iShares Biotechnology ETF (NASDAQ:IBB) closed at $202.93 USD, gaining $0.29 (0.14%) from the previous close of $202.64. The stock is currently mid-range between its 52-week high and low $138.79 and $217.12. With a market capitalization of about $10.02 billion, iShares Biotechnology ETF is classified as a large-cap and shows lower-than-market volatility (beta ~0.71). Key stats such as the average daily volume over the past year has been around 1.59 million shares, in line with its 52-week average. Headquartered in San Francisco, CA, iShares Biotechnology ETF operates in the Financial Services sector and the Asset Management industry. The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index.

Our AI price prediction model suggests that iShares Biotechnology ETF stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

currently trading near 52-week highs band.